| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.087 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |